Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
2.
J Endocrinol Invest ; 17(3): 171-9, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8051339

ABSTRACT

Very Low Calorie Diet (VLCD) is known to induce not only weight loss, but also an improvement of metabolic control, in obese type II diabetics. In order to evaluate the therapeutical efficacy of cycles of VLCD shorter than those previously described, 29 obese type II diabetics and 31 obese nondiabetic subjects were entered as inpatients and prescribed a 450 kcal/day diet for 15 days. Metabolic results obtained were similar to those achieved with longer cycles of VLCD, showing that 15 days are sufficient to induce a BMI decrease in diabetic (BMI from 35.3 +/- 4.8 to 33.3 +/- 4.6 after VLCD) and nondiabetic patients (BMI from 40.5 +/- 7.4 to 38.1 +/- 7.2 after VLCD), a desired fall of blood glucose levels and the decrease of daily insulin needs in insulin-treated patients. Glucagon tests were performed before and after VLCD in order to study possible modifications of insulin secretion. Although we did not observe any significant increase of C-peptide basal or peak levels (nM/ml) either in diabetic (basal levels before VLDC: 1.2 +/- 0.4 and peak levels 2.4 +/- 0.7; basal after VLCD 1.23 +/- 0.6 and peak 2.6 +/- 0.7) and nondiabetic patients (basal levels before VLDC 1.0 +/- 0.3 and peak levels 2.5 +/- 0.4; basal after VLCD 0.9 +/- 0.3 and peak 2.4 +/- 0.6). The rise of the C-peptide/glycemia ratio is an index of an improvement of insulin biological activity, which could be partly responsible for the therapeutical effects of VLCD.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Diabetes Mellitus, Type 2/diet therapy , Diabetes Mellitus/diet therapy , Diet, Reducing , Obesity , Adult , Blood Glucose/metabolism , C-Peptide/blood , Diabetes Mellitus/metabolism , Diabetes Mellitus, Type 2/metabolism , Energy Intake , Female , Glucagon , Humans , Insulin/metabolism , Insulin Secretion , Male , Middle Aged , Receptor, Insulin/physiology , Weight Loss
3.
G Clin Med ; 71(8-9): 507-11, 514-5, 1990.
Article in Italian | MEDLINE | ID: mdl-2279626

ABSTRACT

The Authors have used, on a group of 51 patients, a score-system for the clinical diagnosis of pulmonary embolism. This system is based on clinical examination of the patients and utilizes a different value for each sign and symptom: each sign and symptom correspond to a positive number. Every patients was also undergone instrumental tests to confirm the diagnosis (i.e.: perfusion lung scanning and venous doppler) according to previously defined diagnostic program. A good relationship between the instrumental diagnosis and clinical probability was found with above mentioned score-system. The AA believe that this score-system is valid and that it can be used in elaborating diagnostic decision, particularly in those cases in which the diagnosis is not established by the instrumental tests and in which is not possible to perform pulmonary angiography.


Subject(s)
Pulmonary Embolism/diagnosis , Diagnosis, Differential , Electrocardiography , Female , Humans , Male , Middle Aged , Pulmonary Embolism/diagnostic imaging , Radiography , Radionuclide Imaging
4.
Acta Endocrinol (Copenh) ; 121(6): 759-66, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2692373

ABSTRACT

To clarify the role of insulin, IGF-I and TSH in thyroid cell regulation, their effects on amino acid transport were studied separately. These effects were noted and compared using both the Wistar rat thyroid cell line and human thyroid cell cultures. Insulin, IGF-I and TSH were able independently to induce the radiolabelled alpha-aminoisobutyric acid transport within the rat thyroid cells: TSH stimulated the amino acid transport in rat thyroid cells in a dose-dependent way from 1 pmol/l to 10 nmol/l. Similarly, insulin increased amino acid transport significantly from 0.17 nmol/l up to 0.17 mumol/l and IGF-I from 0.13 pmol/l up to 0.13 mumol/l. The combined effects of insulin and TSH on amino acid transport were equal to the theoretical sum of the activities, whereas those of IGF-I and TSH were greater than the theoretical one. When human thyroid cell cultures were used, a significant increase of labelled amino acid transport was induced by TSH, i.e. from 0.1 pmol/l to 10 pmol/l; IGF-I stimulated amino acid transport in a range from 0.13 pmol/l to 13 pmol/l, under the same conditions. Conversely, only large doses of insulin, i.e. 1.7 nmol/l, were able weakly to stimulate amino acid transport. When submaximal TSH and IGF-I doses were co-incubated in human thyroid cells, an additive effect on amino acid transport was observed.


Subject(s)
Aminoisobutyric Acids/pharmacokinetics , Thyroid Gland/metabolism , Adult , Aged , Animals , Cell Line , Clone Cells , Dose-Response Relationship, Drug , Female , Humans , Insulin/pharmacology , Insulin-Like Growth Factor I/pharmacology , Male , Middle Aged , Rats , Rats, Inbred Strains , Thyroid Gland/cytology , Thyrotropin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...